(Q35589066)

9 August 2017

0 references

Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report (English)

1 reference

9 August 2017

0 references

K Tanaka

1

1 reference

9 August 2017

T Honna

2

1 reference

9 August 2017

Y Kitano

3

1 reference

9 August 2017

T Kuroda

4

1 reference

9 August 2017

K Tanaka

5

1 reference

9 August 2017

N Morikawa

6

1 reference

9 August 2017

H Matsuda

7

1 reference

9 August 2017

N Kawashima

8

1 reference

9 August 2017

K Matsuoka

9

1 reference

9 August 2017

J Miyauchi

10

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Journal of Clinical Pathology

9 August 2017

1 reference

9 August 2017

58

1 reference

9 August 2017

8

1 reference

9 August 2017

884-887

1 reference

Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770866

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770866

An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770866

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770866

Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770866

Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770866

Combined hepatocellular-cholangiocarcinoma: a clinicopathological study

26 September 2018

1 reference

12 December 2020

Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood

1 reference

12 December 2020

Transformation of fibrolamellar carcinoma to common hepatocellular carcinoma in the recurrent lesions of the rectum and the residual liver: a case report

1 reference

12 December 2020

Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers

1 reference

12 December 2020

Adult-type hepatocellular carcinoma in the center of a fibrolamellar hepatocellular carcinoma

1 reference

12 December 2020

Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma

1 reference

12 December 2020

Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features

1 reference

12 December 2020

Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis

1 reference

12 December 2020

Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma

1 reference

12 December 2020

Hepatocellular carcinoma in young people

1 reference

12 December 2020

Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features

1 reference

12 December 2020

An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.2004.021956

1 reference

9 August 2017

1 reference

9 August 2017

1 reference